鹿鼎公韦小宝
08-18
重组呼吸道合胞病毒疫苗(CHO细胞)(佐剂)IND申请,成为公司首个实现中美双报且同时获批临床的品种。难怪中慧的机构这么团结,原来是有重大利好出台啊。
$中慧生物-B(02627)$
中慧生物上市涨近4倍!还能继续拿着吗?
中慧生物-B(02627)旗下慧尔康欣作为唯一疫苗入选国家医保创新药品初审名单。中慧生物表现抢眼,周一(18日)盘中股价上扬,其股价较招股价12.90港元已涨近4倍。【中慧生物你有吃到肉吗?医药赛道热门股,中慧生物你会继续拿着吗?】
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":469011781660872,"tweetId":"469011781660872","gmtCreate":1755527198652,"gmtModify":1755527210490,"author":{"id":10000000000010492,"idStr":"10000000000010491","authorId":10000000000010492,"authorIdStr":"10000000000010491","name":"鹿鼎公韦小宝","avatar":"https://static.tigerbbs.com/acbcdba23abf01629ff9868ac714915f","vip":8,"userType":8,"introduction":".","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":142,"starInvestorFlag":false},"themes":[{"themeId":"c84bf6b420c54df386ed96129eb27e88","categoryId":"7ba93224048e4975aa9a5a60d7f2353b","name":"中慧生物上市涨近4倍!还能继续拿着吗?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":c84bf6b420c54df386ed96129eb27e88}&rnconfig={\"headerBarHidden\": true}","description":"中慧生物-B(02627)旗下慧尔康欣作为唯一疫苗入选国家医保创新药品初审名单。中慧生物表现抢眼,周一(18日)盘中股价上扬,其股价较招股价12.90港元已涨近4倍。【中慧生物你有吃到肉吗?医药赛道热门股,中慧生物你会继续拿着吗?】","image":"https://static.tigerbbs.com/b32d71f11ad9e1cd466781f24a032d65"}],"images":[{"img":"https://static.tigerbbs.com/5a9434db5d09362b4ebd0f10b0d33ef1","width":"540","height":"174"}],"coverImages":[{"img":"https://static.tigerbbs.com/5a9434db5d09362b4ebd0f10b0d33ef1","width":"540","height":"174"}],"html":"<html><head></head><body><p>重组呼吸道合胞病毒疫苗(CHO细胞)(佐剂)IND申请,成为公司首个实现中美双报且同时获批临床的品种。难怪中慧的机构这么团结,原来是有重大利好出台啊。 <a data-mention-id=\"02627\" class=\"teditor-mention\" data-mention-name=\"中慧生物-B\" href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$</a> </p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5a9434db5d09362b4ebd0f10b0d33ef1\" tg-width=\"540\" tg-height=\"174\"></p></body></html>","htmlText":"<html><head></head><body><p>重组呼吸道合胞病毒疫苗(CHO细胞)(佐剂)IND申请,成为公司首个实现中美双报且同时获批临床的品种。难怪中慧的机构这么团结,原来是有重大利好出台啊。 <a data-mention-id=\"02627\" class=\"teditor-mention\" data-mention-name=\"中慧生物-B\" href=\"https://laohu8.com/S/02627\">$中慧生物-B(02627)$</a> </p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5a9434db5d09362b4ebd0f10b0d33ef1\" tg-width=\"540\" tg-height=\"174\"></p></body></html>","text":"重组呼吸道合胞病毒疫苗(CHO细胞)(佐剂)IND申请,成为公司首个实现中美双报且同时获批临床的品种。难怪中慧的机构这么团结,原来是有重大利好出台啊。 $中慧生物-B(02627)$","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/469011781660872","repostId":0,"isVote":1,"tweetType":1,"viewCount":734,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02627"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":true,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":155,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/469011781660872"}
精彩评论